2012
DOI: 10.1684/mst.2012.0016
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among blood donors in Segou, Mali

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 0 publications
1
5
0
Order By: Relevance
“…This male was already provided by other African writers in Nigeria, Mali, Niger, Ivory Coast and Cameroon [ 4 – 6 , 16 , 17 ]. The average age of our donors was similar to that reported by other African studies in Mali, Nigeria and Cameroon [ 4 , 5 , 17 ]. In our study, the overall prevalence of biomarkers studied in blood donors was 16.2%.…”
Section: Discussionsupporting
confidence: 87%
“…This male was already provided by other African writers in Nigeria, Mali, Niger, Ivory Coast and Cameroon [ 4 – 6 , 16 , 17 ]. The average age of our donors was similar to that reported by other African studies in Mali, Nigeria and Cameroon [ 4 , 5 , 17 ]. In our study, the overall prevalence of biomarkers studied in blood donors was 16.2%.…”
Section: Discussionsupporting
confidence: 87%
“…patients with liver disease, HIV-positive subjects, [ 11 , 18 , 19 ]) or low-risk (e.g. blood donors, [ 10 , 12 , 17 ]) subjects. Several studies have analyzed seroprevalence in pregnant women and in women of childbearing age [ 13 - 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…In conclusion, this study provides a detailed assessment of HB chronic infection status in a group of subjects, unselected for clinical symptoms, in Bamako-Mali. Previous studies in Mali and in West Africa have mostly addressed HB status in specific groups such as blood donors [ 10 , 12 , 17 ], pregnant women [ 13 , 16 ], or patients diagnosed with chronic active hepatitis [ 35 ]. The results show that the rate of HB carriage in the population of Bamako is in the higher range of estimates for West Africa, and that about 30% of adult carriers have HB and/or liver biomarkers that would qualify them for treatment with HB anti-viral therapies.…”
Section: Discussionmentioning
confidence: 99%
“…This window, which is immunologically silent, separates the date of the contamination from the one in which the HBV markers appear, which justifies the negativity of the tests at this period, hence the interest of the PCR. Indeed, for Kone et al, the safety of blood transfusion would be ensured by strategies that should be directed towards the abandonment of family blood donation such as the promotion of volunteer donation, loyalty and the organization of donors in clubs [9]. Naila et al claim that in Pakistan the risk of HBV transmission is higher among replacement donors (family) because this category is in fact associated with poor people, who are secretly paid by the family and who conceal information during the selection interview [10].…”
Section: Discussionmentioning
confidence: 99%